Skip to Main Content

Paper Details

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Eur Urol
259
2020
Advanced Prostate Cancer, PATIENT, Patients, Prostate Cancer, advanced prostate cancer, bone metastases, health, hormone-sensitive/nave prostate cancer, men, metastatic, metastatic castration-resistant prostate cancer, nonmetastatic castration-resistant prostate cancer, patient, patients, prostate cancer, tumour
Author NameAffiliation
Gerhardt AttardUniversity College London Cancer Institute
Tomasz M BeerKnight Cancer Institute, Oregon Health & Science University
Himisha BeltranDana-Farber Cancer Institute, USA Brigham and Women's Hospital, Harvard Medical School
Himisha BeltranDana-Farber Cancer Institute, USA Brigham and Women's Hospital, Harvard Medical School
Anders BjartellSkane University Hospital
Alberto BrigantiIRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University
Robert G BristowUniversity of Manchester, UK Christie NHS Trust, UK CRUK Manchester Institute and Cancer Centre
Kim N ChiUniversity of British Columbia
Johann S de BonoThe Institute of Cancer Research/Royal Marsden NHS Foundation Trust
Douglas F EastonThe Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Eleni EfstathiouUniversity of Texas MD Anderson Cancer Center
Christopher P EvansUniversity of California Davis School of Medicine
Felix Y FengUniversity of California San Francisco
Mark FrydenbergMonash University
Martin E GleaveUniversity of British Columbia
Celestia S HiganoUniversity of Washington, USA Fred Hutchinson Cancer Research Center
Maha HussainRobert H. Lurie Comprehensive Cancer Center, Northwestern University
Philip W KantoffMemorial Sloan Kettering Cancer Center, USA Weill Cornell Medical College
Philip W KantoffMemorial Sloan Kettering Cancer Center, USA Weill Cornell Medical College
Michael J MorrisMemorial Sloan Kettering Cancer Center
Nicolas MottetUniversity Hospital Nord
Declan G MurphyPeter MacCallum Cancer Centre, University of Melbourne
William K OhIcahn School of Medicine at Mount Sinai, The Tisch Cancer Institute
Piet OstGhent University Hospital
Colin C PritchardUniversity of Washington
Robert E ReiterUniversity of California Los Angeles
Mack RoachUCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco
Mark A RubinBern Center for Precision Medicine, University of Bern
Mark A RubinBern Center for Precision Medicine, University of Bern
Fred SaadCentre Hospitalier de Universite de Montreal
Oliver SartorTulane Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Eric J SmallUCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco
Cora N SternbergEnglander Institute for Precision Medicine
Mary-Ellen TaplinDana-Farber Cancer Institute, USA Brigham and Women's Hospital, Harvard Medical School
Inge M van OortRadboud University Medical Center
Almudena ZapateroUniversity Hospital La Princesa, Health Research Institute
  • 1 - 37

Datasets